Riess, O.
500  Ergebnisse:
Personensuche X
?
2

APPLICATION OF NEXT GENERATION TECHNOLOGIES:

Atalaia, A. ; Thompson, R. ; Matalonga, L....
Neuromuscular Disorders.  31 (2021)  - p. S146-S147 , 2021
 
?
3

The Undiagnosed Diseases Network International: Five years ..:

Taruscio, D. ; Baynam, G. ; Cederroth, H....
Molecular Genetics and Metabolism.  129 (2020)  4 - p. 243-254 , 2020
 
?
5

EP-1074: Circulating cell free DNA: dynamics in patients wi..:

Zwirner, K. ; Hilke, F. ; Schroeder, C....
Radiotherapy and Oncology.  119 (2016)  - p. S516-S517 , 2016
 
?
6

NeurOmics: EU-funded-omics research for diagnosis and thera..:

Turner, C. ; Brice, A. ; Bushby, K....
Neuromuscular Disorders.  25 (2015)  - p. S298-S299 , 2015
 
?
11

PIK3R1mutations in SHORT syndrome:

Schroeder, C. ; Riess, A. ; Bonin, M....
Clinical Genetics.  86 (2013)  3 - p. 292-294 , 2013
 
?
 
?
13

3.309 THE GUANINE NUCLEOTIDE EXCHANGE FACTOR KALIRIN-7 IS A..:

Tsai, Y.C. ; Riess, O. ; Soehn, A.S..
Parkinsonism & Related Disorders.  18 (2012)  - p. S221 , 2012
 
?
14

Calpain-mediated ataxin-3 cleavage in the molecular pathoge..:

Hubener, J. ; Weber, J. J. ; Richter, C....
Human Molecular Genetics.  22 (2012)  3 - p. 508-518 , 2012
 
?
15

3.062 ATAXIN-2 INTERMEDIATE POLYGLUTAMINE EXPANSIONS CONTRI..:

Gispert, S. ; Kurz, A. ; Waibel, S....
Parkinsonism & Related Disorders.  18 (2012)  - p. S184 , 2012
 
1-15